$0.6680
0.02333.61%
最終更新: Oct 15, 4:28 PM
$0.6500
0.00530.82%
Benzinga
Benzinga
Benzinga
土曜日, 10 17
Benzinga
© 2026 Benzinga | All Rights Reserved
Envoy Medical (COCH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.08 | $-0.14 | $-0.24 | $-0.28 |
| Actual | $-0.07 | $-0.08 | $-0.26 | $-0.35 |
| Surprise | +12.5% | +42.9% | -8.33% | -25.0% |
| Revenue | ||||
| Estimate | $76000 | $60000 | $30000 | $72000 |
| Actual | $51000 | $39000 | $75000 | $42000 |
| Surprise | -32.9% | -35.0% | +150.0% | -41.7% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.07 | $-0.07 | $-0.06 | $-0.05 |
| Revenue | ||||
| Consensus | $80000 | $80000 | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.07 | $-0.08 | 12.5 % |
| Q1 | May 11, 2026 | $-0.08 | $-0.14 | 42.9 % |
| Q4 | Mar 23, 2026 | $-0.26 | $-0.24 | -8.33 % |
| Q3 | Nov 10, 2025 | $-0.35 | $-0.28 | -25.0 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $51.00K | $76.00K | -32.9 % |
| Q1 | May 11, 2026 | $39.00K | $60.00K | -35.0 % |
| Q4 | Mar 23, 2026 | $75.00K | $30.00K | 150.0 % |
| Q3 | Nov 10, 2025 | $42.00K | $72.00K | -41.7 % |